Ardent Health Partners (ARDT)

NYSE: ARDT · Real-Time Price · USD

13.19

0.60 (4.77%)

At close: May 02, 2025, 3:59 PM

13.17

-0.15%

After-hours: May 02, 2025, 04:05 PM EDT

Ardent Health Partners Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017
Revenue	5.97B	5.71B	5.63B	5.53B	5.41B	4.06B	2.69B	1.32B	4.16B	4.79B	4.49B	4.18B	3.88B	2.15B	1.37B	685.11M
Cost of Revenue	1.6B	1.58B	766.86M	542.14M	319.06M	69.37M	69.37M	34.7M	959.36M	2.22B	2.59B	2.43B	2.27B	1B	636.93M	318.46M
Gross Profit	4.37B	4.13B	4.87B	4.99B	5.09B	3.99B	2.62B	1.28B	3.2B	2.57B	1.9B	1.76B	1.61B	1.15B	733.28M	366.64M
Operating Income	135.99M	-10.26M	-67.33M	176.59M	151.98M	140.66M	140.66M	54.15M	358.16M	275.45M	327.48M	300.57M	273.67M	303.91M	199.77M	99.88M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	363.06M	196.76M	185.66M	171.29M	143.73M	142.79M	96.82M	29M	-114.62M	-204.72M	-230.04M	-179.47M	-128.9M	29.69M	31.03M	15.51M
Net Income	210.33M	88.36M	82.88M	73.18M	50.29M	58.06M	37.22M	4.14M	-143.02M	-214.12M	-226.38M	-184.72M	-143.06M	521K	7.29M	3.65M
Selling & General & Admin	3.19B	3.12B	3.75B	3.69B	3.62B	2.68B	1.78B	885.37M	2.76B	2.92B	2.22B	2.1B	1.99B	826.14M	522.11M	261.06M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	15.7M	12.9M	15.2M	16.35M	17.5M	17.5M	11.4M	5.7M
Other Expenses	1.31B	1.28B	1.45B	1.51B	1.44B	1.29B	816.72M	342.76M	n/a	564.63M	564.63M	564.63M	564.63M	n/a	n/a	n/a
Operating Expenses	4.5B	4.4B	5.2B	5.2B	5.06B	3.97B	2.6B	1.23B	2.77B	3.49B	2.8B	2.69B	2.57B	843.64M	533.51M	266.76M
Interest Expense	63.36M	59.4M	63.81M	64.34M	65.42M	55.85M	36.81M	18.12M	50.48M	90.39M	62.05M	62.05M	62.05M	n/a	n/a	n/a
Selling & Marketing Expenses	254.85M	254.85M	254.85M	254.85M	n/a	n/a	n/a	n/a	1.18B	728.58M	671.86M	608.38M	544.9M	544.9M	348.79M	174.4M
Cost & Expenses	6.09B	5.98B	5.97B	5.62B	5.26B	3.93B	2.55B	1.26B	3.8B	4.49B	4.13B	3.85B	3.57B	1.85B	1.17B	585.22M
Income Tax Expense	63.35M	33.19M	29.39M	26.28M	20.78M	24.59M	17.33M	5.22M	14.19M	-5.64M	-8.09M	-11.31M	-14.52M	9.41M	6.31M	3.16M
Shares Outstanding (Basic)	142.75M	137.11M	142.76M	143.26M	142.11M	140.96M	142.76M	143.26M	473.81M	140.96M	385.54M	385.54M	n/a	n/a	n/a	n/a
Shares Outstanding (Diluted)	142.75M	137.54M	142.76M	143.26M	142.11M	140.96M	142.76M	143.26M	473.81M	140.96M	385.54M	385.54M	n/a	n/a	n/a	n/a
EPS (Basic)	1.54	0.63	0.59	0.52	0.35	0.41	0.26	0.03	-0.67	-0.16	-0.2	-0.1	n/a	n/a	n/a	n/a
EPS (Diluted)	1.54	0.63	0.59	0.52	0.35	0.41	0.26	0.03	-0.67	-0.16	-0.2	-0.1	n/a	n/a	n/a	n/a
EBITDA	567.56M	399.08M	391.11M	375.63M	350M	303.5M	203M	81.82M	282.22M	175.99M	133.65M	134.19M	134.74M	154.82M	107.36M	53.68M
EBIT	424.92M	254.66M	247.97M	234.14M	209.15M	198.64M	133.63M	47.12M	138.65M	-10.37M	-43.11M	-30.84M	-18.58M	77.97M	58.6M	29.3M
Depreciation & Amortization	146.29M	144.42M	143.13M	141.49M	140.84M	104.86M	69.37M	34.7M	143.19M	142.57M	132.97M	121.25M	109.53M	76.85M	48.76M	24.38M